First Time Loading...

Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 2.93 USD 5.02% Market Closed
Updated: May 3, 2024

Adaptive Biotechnologies Corp
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adaptive Biotechnologies Corp
Cash from Financing Activities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Cash from Financing Activities
$2.2m
CAGR 3-Years
-80%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Financing Activities
-$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Cash from Financing Activities
-$144m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
17%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Financing Activities
-$859.6m
CAGR 3-Years
-5%
CAGR 5-Years
-17%
CAGR 10-Years
-13%
Agilent Technologies Inc
NYSE:A
Cash from Financing Activities
-$1.2B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
-8%
IQVIA Holdings Inc
NYSE:IQV
Cash from Financing Activities
-$382m
CAGR 3-Years
-21%
CAGR 5-Years
3%
CAGR 10-Years
N/A

See Also

What is Adaptive Biotechnologies Corp's Cash from Financing Activities?
Cash from Financing Activities
2.2m USD

Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Cash from Financing Activities amounts to 2.2m USD.

What is Adaptive Biotechnologies Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
13%

Over the last year, the Cash from Financing Activities growth was -98%. The average annual Cash from Financing Activities growth rates for Adaptive Biotechnologies Corp have been -80% over the past three years , 13% over the past five years .